ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 176 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $68,771,000 | +65.4% | 11,404,974 | -1.3% | 0.00% | +50.0% |
| Q3 2019 | $41,585,000 | +36.1% | 11,551,656 | +1.3% | 0.00% | +100.0% |
| Q2 2019 | $30,561,000 | -9.9% | 11,403,516 | -0.5% | 0.00% | -50.0% |
| Q1 2019 | $33,926,000 | +76.3% | 11,461,852 | -5.3% | 0.00% | +100.0% |
| Q4 2018 | $19,241,000 | -56.2% | 12,101,177 | +1.5% | 0.00% | -50.0% |
| Q3 2018 | $43,885,000 | +30.7% | 11,925,359 | +0.5% | 0.00% | 0.0% |
| Q2 2018 | $33,575,000 | -22.7% | 11,863,676 | +1.4% | 0.00% | 0.0% |
| Q1 2018 | $43,422,000 | +30.3% | 11,703,982 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $33,326,000 | -24.5% | 11,572,015 | +17.7% | 0.00% | 0.0% |
| Q3 2017 | $44,163,000 | +1.0% | 9,835,891 | +3.2% | 0.00% | 0.0% |
| Q2 2017 | $43,744,000 | +4.9% | 9,530,142 | -3.8% | 0.00% | 0.0% |
| Q1 2017 | $41,714,000 | +18115.7% | 9,908,372 | +17844.4% | 0.00% | – |
| Q4 2016 | $229,000 | -40.5% | 55,217 | +16.4% | 0.00% | -100.0% |
| Q3 2016 | $385,000 | +100.5% | 47,440 | +92.4% | 0.00% | – |
| Q2 2016 | $192,000 | +214.8% | 24,652 | +210.2% | 0.00% | – |
| Q1 2016 | $61,000 | +41.9% | 7,947 | +97.6% | 0.00% | – |
| Q4 2015 | $43,000 | +115.0% | 4,022 | +39.9% | 0.00% | – |
| Q3 2015 | $20,000 | -23.1% | 2,874 | 0.0% | 0.00% | – |
| Q2 2015 | $26,000 | -10.3% | 2,874 | -5.0% | 0.00% | – |
| Q1 2015 | $29,000 | -12.1% | 3,026 | +9.5% | 0.00% | – |
| Q4 2014 | $33,000 | -86.8% | 2,763 | -89.0% | 0.00% | – |
| Q3 2014 | $250,000 | +1036.4% | 25,090 | +768.8% | 0.00% | – |
| Q2 2014 | $22,000 | +144.4% | 2,888 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | 0.0% | 2,888 | 0.0% | 0.00% | – |
| Q4 2013 | $9,000 | +12.5% | 2,888 | 0.0% | 0.00% | – |
| Q3 2013 | $8,000 | -66.7% | 2,888 | 0.0% | 0.00% | – |
| Q2 2013 | $24,000 | – | 2,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |